News from Quanterix Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

11 Oct, 2012, 09:00 ET Quanterix's Ultrasensitive Simoa™ Technology Demonstrates Equivalence with NAT and 3,000x Improvement in Sensitivity over Conventional Immunoassays for HIV Detection

 Quanterix Corporation announced today that the Journal of Virological Methods published a key study describing the application of its...


20 Jul, 2012, 11:36 ET Quanterix Appoints Paul Chapman as President and Chief Executive Officer

 Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its...


09 Feb, 2012, 12:00 ET Quanterix to Collaborate With the Forsyth Institute and Beth Israel Deaconess Medical Center to Develop Tuberculosis Test

 Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


22 Dec, 2011, 08:30 ET Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology

 Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule...


01 Dec, 2011, 08:30 ET Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


02 Nov, 2011, 08:30 ET Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


13 Oct, 2011, 11:00 ET Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


19 Sep, 2011, 10:37 ET Dr. Martin Madaus Joins Quanterix as CEO

Quanterix Corporation, using its revolutionary Single Molecule Array (SiMoA™) technology to enable unprecedented high value research and...


19 Aug, 2011, 10:02 ET Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohn's Disease

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


16 Aug, 2011, 08:00 ET Quanterix and STRATEC Announce Strategic Partnership

Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array...


21 Jul, 2011, 09:00 ET Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance

Quanterix Corporation, an in-vitro diagnostics (IVD) company providing life science researchers and IVD labs single molecule technology with...


20 Jul, 2011, 08:00 ET Quanterix and Sony DADC to Develop and Manufacture Smart Consumables for Life Science and In Vitro Diagnostic Applications

Quanterix Corporation, enabling a new generation of diagnostic tests based on the revolutionary Single Molecule Array (SiMoA™) technology,...


12 Apr, 2011, 13:30 ET Quanterix Discovers Link Between Heart Attack-Induced Hypoxia and Suspected Alzheimer's Disease Pathway

Quanterix Corporation, enabling a new generation of diagnostics based on revolutionary Single Molecule Array (SiMoA™) technology, today...


23 Feb, 2011, 10:38 ET Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability

Quanterix Corporation, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro...


22 Feb, 2011, 07:30 ET Quanterix Announces New Technology Evaluation Agreement

Quanterix Corporation, enabling a new generation of diagnostic tests based on revolutionary Single Molecule Array (SiMoA™) technology, today...


01 Dec, 2010, 08:30 ET Dr. Martin Madaus Joins Quanterix Board of Directors

Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company's Board as Executive Chairman. Dr. Madaus brings more than...


02 Nov, 2010, 12:26 ET Quanterix Awarded $733,437 in Qualifying Therapeutic Discovery Project (QTDP) Grants

Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it...


23 May, 2010, 13:00 ET Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer

Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the...


02 Sep, 2009, 09:00 ET Dr. David Okrongly Appointed CEO of Quanterix Corporation

Quanterix Corporation, the leader in single molecule detection, announced today that David Okrongly, Ph.D. has been appointed Chief Executive...


11 Nov, 2008, 11:30 ET Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board

Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board...


30 Sep, 2008, 01:00 ET Quanterix Corporation Awarded $185,000 Grant from the National Cancer Institute

CAMBRIDGE, Mass., Sept. 30 /PRNewswire/ -- Quanterix Corporation, the leader in single molecule protein detection, announced today that it has...